Bastide Le Confort MedicalFRA:1DJ +7.27%70 EBITDA Margin % is 20.46% as of Dec. 2025, which is 9% above its 10-year median of 18.79. GuruFocus rates FRA:1DJ with a GF Score™ of 70/100 and a GF Value™ of €25.12 (Fairly Valued). The stock has 2 warning signs investors should review. Among 119 Medical Distribution companies, Bastide Le Confort Medical ranks better than 94.12% on this metric.
Bastide Le Confort Medical (FRA:1DJ) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Bastide Le Confort Medical EBITDA Margin % Related Terms
Bastide Le Confort Medical EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1DJ vs MCK, COR, CAH: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Bastide Le Confort Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bastide Le Confort Medical EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Bastide Le Confort Medical's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Bastide Le Confort Medical's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bastide Le Confort Medical (FRA:1DJ) has a EBITDA Margin % of 20.46% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bastide Le Confort Medical and its competitors. This is near median its historical median of 18.79. Over the past decade, Bastide Le Confort Medical's EBITDA Margin % has ranged from 16.19 to 20.77. According to the industry distribution chart, Bastide Le Confort Medical ranks #7 out of 119 companies in the Medical Distribution industry, placing it in the top 5.9%.
Is Bastide Le Confort Medical's EBITDA Margin % too high?
Bastide Le Confort Medical's current EBITDA Margin % of 20.46% is near median its 10-year median of 18.79. Over the past 10 years, this metric has ranged from a low of 16.19 to a high of 20.77. The Medical Distribution industry median EBITDA Margin % is 4.31. Bastide Le Confort Medical's value of 20.46% is 374.7% above this industry median. Based on the distribution chart, Bastide Le Confort Medical ranks #7 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Bastide Le Confort Medical has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bastide Le Confort Medical's EBITDA Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Bastide Le Confort Medical ranks #7 out of 119 companies for EBITDA Margin %. This places Bastide Le Confort Medical in the top 6% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 4.31. Bastide Le Confort Medical's value of 20.46% is 374.7% above this benchmark. Historically, Bastide Le Confort Medical's own EBITDA Margin % has ranged from 16.19 to 20.77 over the past decade. While the company's 10-year median is 18.79 vs. the industry median of 4.31, Bastide Le Confort Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.31, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bastide Le Confort Medical's current EBITDA Margin % of 20.46% is 374.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bastide Le Confort Medical and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bastide Le Confort Medical's current EBITDA Margin % is 20.46%, which is near median its own 10-year median of 18.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bastide Le Confort Medical stock overvalued right now?
Based on GuruFocus' analysis, Bastide Le Confort Medical (FRA:1DJ) is currently considered Fairly Valued. The stock's GF Value™ is €25.12, compared to a current price of €24.35 — trading 3.1% below its estimated fair value. The current EBITDA Margin % is 20.46%, which is near median its 10-year median of 18.79 and 374.7% above the Medical Distribution industry median of 4.31. Bastide Le Confort Medical's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Bastide Le Confort Medical (FRA:1DJ), the current EBITDA Margin % is 20.46% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bastide Le Confort Medical (FRA:1DJ) Overvalued in 2026?
Based on GuruFocus' analysis, Bastide Le Confort Medical stock appears to be undervalued.
The current stock price of €24.35 is trading 3.1% below its estimated GF Value™ of €25.12.
GuruFocus considers Bastide Le Confort Medical to be Fairly Valued.
Key valuation signals for FRA:1DJ:
EBITDA Margin %: 20.46% (near median its 10-year median of 18.79)
GF Value™: €25.12 vs. price of €24.35 (3.1% below fair value)
Industry Position: 374.7% above the Medical Distribution median (#7 of 119)
No single metric tells the full story. See the FRA:1DJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bastide Le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for the home care of the elderly, sick and disabled. The company provides care equipment, such as hospital beds, personal assistance products, nutrition, insulin pumps, and syringe-drivers.
70GF Score
Get the complete analysis for FRA:1DJ
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1DJ has been successfully added to your 
